Résumé
Certains cas cliniques d’œdèmes maculaires sont associés à des affections oculaires (telles qu’une radiothérapie pour mélanome oculaire) et ont un pronostic relativement sévère lié à l’affection primitive elle-même. Au contraire, les oedèmes maculaires survenant après décollement de rétine ou après diverses affections et divers traitements systémiques ou locaux sont habituellement temporaires.
Les oedèmes maculaires associés aux membranes épirétiniennes ou à une traction vitréo-maculaire restent la cause essentielle d’une récupération fonctionnelle relativement limitée.
Dans les autres cas, tels que le vitréoschisis myopique par traction, le délai pour observer une amélioration visuelle significative après chirurgie pourrait être relativement très long.
Enfin, les oedèmes maculaires associés avec des hémangiomes et des macro-anévrismes pourraient être traités s’ils sont symptomatiques, en utilisant les mêmes thérapies habituelles que pour l’oedème maculaire diabétique ou les oedèmes observés dans la dégénérescence maculaire exsudative
Preview
Unable to display preview. Download preview PDF.
Références
Finger PT (1997) Radiation therapy for choroidal melanoma. Surv Ophthalmol 42: 215–232
Finger PT, Chin KJ, et al. (2009) Palladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 treated patients. Ophthalmology 116: 790–796, 796 e1
Finger PT (2000) Tumour location affects the incidence of cataract and retinopathy after ophthalmic plaque radiation therapy. Br J Ophthalmol 84: 1068–1070
Hykin PG, Shields CL, et al. (1998) The efficacy of focal laser therapy in radiation-induced macular edema. Ophthalmology 105: 1425–1429
Kinyoun JL, Zamber RW, et al. (1995) Photocoagulation treatment for clinically significant radiation macular oedema. Br J Ophthalmol 79: 144–149
Sutter FK, Gillies MC (2003) Intravitreal triamcinolone for radiation-induced macular edema. Arch Ophthalmol 121: 1491–1493
Gillies MC (1999) Regulators of vascular permeability: potential sites for intervention in the treatment of macular edema. Doc Ophthalmol 97: 251–260
Finger RP, Charbel Issa P, et al. (2008) Intravitreal bevacizumab for choroidal neovascularisation associated with pseudoxanthoma elasticum. Br J Ophthalmol 92: 483–487
Hoyng PF, Rulo AH, et al. (1997) Fluorescein angiographic evaluation of the effect of latanoprost treatment on bloodretinal barrier integrity: a review of studies conducted on pseudophakic glaucoma patients and on phakic and aphakic monkeys. Surv Ophthalmol 41Suppl 2: S83–S88
Schumer RA, Camras CB, et al. (2000) Latanoprost and cystoid macular edema: is there a causal relation? Curr Opin Ophthalmol 11: 94–100
Wand M., Gaudio AR (2002) Cystoid macular edema associated with ocular hypotensive lipids. Am J Ophthalmol 133: 403–405
Schumer RA, Camras CB, et al. (2002) Putative side effects of prostaglandin analogs. Surv Ophthalmol 47Suppl 1: S219
Linden C (2001) Therapeutic potential of prostaglandin analogues in glaucoma. Expert Opin Investig Drugs 10: 679–694
Chang JH, McCluskey P, et al. (2008) Use of ocular hypotensive prostaglandin analogues in patients with uveitis: does their use increase anterior uveitis and cystoid macular oedema? Br J Ophthalmol 92: 916–921
Joshi MM, Garretson BR (2007) Paclitaxel maculopathy. Arch Ophthalmol 125: 709–710
Colucciello M (2005) Vision loss due to macular edema induced by rosiglitazone treatment of diabetes mellitus. Arch Ophthalmol 123: 1273–1275
Ryan EH, Han DP, et al. (2006) Diabetic macular edema associated with glitazone use. Retina 26: 562–570
Sivagnanam G (2006) Rosiglitazone and macular edema. CMAJ 175: 276
Shen LQ, Child A, et al. (2008) Rosiglitazone and delayed onset of proliferative diabetic retinopathy. Arch Ophthalmol 126: 793–799
Fong DS, Contreras R (2009) Glitazone use associated with diabetic macular edema. Am J Ophthalmol 147: 583–586 e1
Margherio RR, Cox MS, et al. (1985) Removal of epimacular membranes. Ophthalmology 92: 1075–1083
Gaudric A, Fardeau C, et al. (1993) [Ablation of the internal limiting membrane, macular unfolding and visual outcome in surgery of idiopathic epimacular membranes]. J Fr Ophtalmol 16: 571–576
Smiddy WE, Green WR, et al. (1989) Ultrastructural studies of vitreomacular traction syndrome. Am J Ophthalmol 107: 177–185
Smiddy WE, Michels RG, et al. (1990) Morphology, pathology, and surgery of idiopathic vitreoretinal macular disorders. A review. Retina 10: 288–2896
Rouhette H, Gastaud P (2001) [Idiopathic vitreomacular traction syndrome. Vitrectomy results]. J Fr Ophtalmol 24: 496–504
Shinoda K, Hirakata A, et al. (2000) Ultrastructural and immunohistochemical findings in five patients with vitreomacular traction syndrome. Retina 20: 289–293
Gandorfer A, Rohleder M, et al. (2002) Epiretinal pathology of vitreomacular traction syndrome. Br J Ophthalmol 86: 902–909
Puliafito CA, Hee MR, et al. (1995) Imaging of macular diseases with optical coherence tomography. Ophthalmology 102: 217–229
Do DV, Cho M, et al. (2007) Impact of optical coherence tomography on surgical decision making for epiretinal membranes and vitreomacular traction. Retina 27: 552–556
Gaudric A, Cohen D (1992) [Surgery of idiopathic epimacular membranes. Prognostic factors]. J Fr Ophtalmol 15: 657–668
Uchino E, Uemura A, et al. (2001) Postsurgical evaluation of idiopathic vitreomacular traction syndrome by optical coherence tomography. Am J Ophthalmol 132: 122–123
Koizumi H, Spaide RF, et al. (2008) Th ree-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography. Am J Ophthalmol 145: 509–517
Gastaud P, Betis F, et al. (2000) [Ultrastructural findings of epimacular membrane and detached posterior hyaloid in vitreomacular traction syndrome]. J Fr Ophtalmol 23: 587–593
Yamada N, Kishi S (2005) Tomographic features and surgical outcomes of vitreomacular traction syndrome. Am J Ophthalmol 139: 112–117
McDonald HR, Johnson RN, et al. (1994) Surgical results in the vitreomacular traction syndrome. Ophthalmology 101: 1397–1402; discussion 1403
Melberg NS, Williams DF, et al. (1995) Vitrectomy for vitreomacular traction syndrome with macular detachment. Retina 15: 192–197
Gaudric A, Haouchine B, et al. (1999) Macular hole formation: new data provided by optical coherence tomography. Arch Ophthalmol 117: 744–751
Johnson MW, Van Newkirk MR, et al. (2001) Perifoveal vitreous detachment is the primary pathogenic event in idiopathic macular hole formation. Arch Ophthalmol 119: 215–222
Abdelkader E, Lois N (2008) Internal limiting membrane peeling in vitreo-retinal surgery. Surv Ophthalmol 53: 368–396
Haritoglou C, Gandorfer A, et al. (2003) The effect of indocyanine-green on functional outcome of macular pucker surgery. Am J Ophthalmol 135: 328–337
Haritoglou C, Gandorfer A, et al. (2004) Anatomic and visual outcomes after indocyanine green-assisted peeling of the retinal internal limiting membrane in idiopathic macular hole surgery. Am J Ophthalmol 138: 691–692; author reply 692
Haritoglou C, Eibl K, et al. (2004) Functional outcome after trypan blue-assisted vitrectomy for macular pucker: a prospective, randomized, comparative trial. Am J Ophthalmol 138: 1–5
Kampik A, Green WR, et al. (1980) Ultrastructural features of progressive idiopathic epiretinal membrane removed by vitreous surgery. Am J Ophthalmol 90: 797–809
Park DW, Dugel PU, et al. (2003) Macular pucker removal with and without internal limiting membrane peeling: pilot study. Ophthalmology 110: 62–64
Sakamoto H, Yamanaka I, et al. (2003) Indocyanine greenassisted peeling of the epiretinal membrane in proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 241: 204–207
Bovey EH, Uffer S, et al. (2004) Surgery for epimacular membrane: impact of retinal internal limiting membrane removal on functional outcome. Retina 24: 728–735
Sivalingam A, Eagle RC, et al. (1990) “Visual prognosis correlated with the presence of internal-limiting membrane in histopathologic specimens obtained from epiretinal membrane surgery. Ophthalmology 97: 1549–1552
Geerts L, Pertile G, et al. (2004) Vitrectomy for epiretinal membranes: visual outcome and prognostic criteria. Bull Soc Belge Ophtalmol 293: 7–15
Kadonosono K, Itoh N, et al. (1999) Capillary blood flow velocity in patients with idiopathic epiretinal membranes. Retina 19: 536–539
Gandorfer A, Messmer EM, et al. (2000) Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 20: 126–133
Kuhn F, Kiss G, et al. (2004) Vitrectomy with internal limiting membrane removal for clinically significant macular oedema. Graefes Arch Clin Exp Ophthalmol 242: 402–408
Kimura T, Kiryu J, et al. (2005) Efficacy of surgical removal of the internal limiting membrane in diabetic cystoid macular edema. Retina 25: 454–461
Tachi N, Ogino N (1996) Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 122: 258–260.
Stolba U, Binder S, et al. (2005) Vitrectomy for persistent diffuse diabetic macular edema. Am J Ophthalmol 140: 295–301
Thomas D, Bunce C, et al. (2005) A randomised controlled feasibility trial of vitrectomy versus laser for diabetic macular oedema. Br J Ophthalmol 89: 81–86
Kiss CG, Richter-Muksch S, et al. (2007) Anatomy and function of the macula after surgery for retinal detachment complicated by proliferative vitreoretinopathy. Am J Ophthalmol 144: 872–877
Bonnet M (1994) Macular changes and fluorescein angiographic findings after repair of proliferative vitreoretinopathy. Retina 14: 404–410
Benson SE, Schlottmann PG, et al. (2006) Optical coherence tomography analysis of the macula after vitrectomy surgery for retinal detachment. Ophthalmology 113: 1179–1183
Schocket LS, Witkin AJ, et al. (2006) Ultrahighresolution optical coherence tomography in patients with decreased visual acuity after retinal detachment repair. Ophthalmology 113: 666–672
Gaucher D, Haouchine B, et al. (2007) Long-term follow-up of high myopic foveoschisis: natural course and surgical outcome. Am J Ophthalmol 143: 455–462
Ikuno Y, Sayanagi K, et al. (2004) Vitrectomy and internal limiting membrane peeling for myopic foveoschisis. Am J Ophthalmol 137: 719–724
Kwok AK, Lai TY, et al. (2005) Vitrectomy and gas tamponade without internal limiting membrane peeling for myopic foveoschisis. Br J Ophthalmol 89: 1180–1183
Shields CL, Honavar SG, et al. (2001) Circumscribed choroidal hemangioma: clinical manifestations and factors predictive of visual outcome in 200 consecutive cases. Ophthalmology 108: 2237–2248
Gunduz K (2004) Transpupillary thermotherapy in the management of circumscribed choroidal hemangioma. Surv Ophthalmol 49: 316–327
Boixadera A, Arumi JG, et al. (2009) Prospective Clinical Trial Evaluating the Efficacy of Photodynamic Therapy for Symptomatic Circumscribed Choroidal Hemangioma. Ophthalmology 116: 100–105e1
Rabb MF, Gagliano DA, et al. (1988) Retinal arterial macroaneurysms. Surv Ophthalmol 33: 73–96
Tsujikawa A, Sakamoto A, et al. (2009) Retinal structural changes associated with retinal arterial macroaneurysm examined with optical coherence tomography. Retina 29: 782–792
Chanana B, Azad RV (2009) Intravitreal bevacizumab for macular edema secondary to retinal macroaneurysm. Eye 23: 493–494
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag France, Paris
About this chapter
Cite this chapter
Creuzot-Garcher, C., Jonas, J., Wolf, S. (2011). Œdèmes maculaires d’origines diverses. In: Œdèmes maculaires. Springer, Paris. https://doi.org/10.1007/978-2-8178-0118-6_12
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0118-6_12
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0117-9
Online ISBN: 978-2-8178-0118-6
eBook Packages: MedicineMedicine (R0)